Effect of O-ag modifying glycosyltransferases on complement activation and <i>Salmonella</i> interactions with human serum. by Fermin E. Guerra (6084545)

O-ag length and composition impacts complement activation by <i>Salmonella</i> nontyphoidal and enteric fever serovars. by Fermin E. Guerra (6084545)

<i>rfbV</i> gene triplication in S. Paratyphi A increases VL O-ag production and reduces C3b deposition. by Fermin E. Guerra (6084545)

<i>S</i>. Paratyphi A has deficient L O-ag production due to R98C mutation in WzzB. by Fermin E. Guerra (6084545)

List of captured wild pollinator species. by Carmelo Gómez-Martínez (9384385)

“…Overall pollinator abundance was slightly higher in ecological than conventional orchards, but the difference was not significant. …”

Reduction of L O-ag production and antigenic shift to O2-antigen in by Fermin E. Guerra (6084545)

Map of the 20 study orchards. by Carmelo Gómez-Martínez (9384385)

“…Overall pollinator abundance was slightly higher in ecological than conventional orchards, but the difference was not significant. …”

Pictures of carob tree flowers and orchard. by Carmelo Gómez-Martínez (9384385)

“…Overall pollinator abundance was slightly higher in ecological than conventional orchards, but the difference was not significant. …”

The contribution of O-ag length and the Vi capsule to serum resistance is serovar dependent. by Fermin E. Guerra (6084545)

Group differences in perceptual bias scores. by Daniel E. Lidstone (21567523)

Subjects:

ASFV-ΔI7L induces higher immune responses than does ASFV-WT in pigs. by Meilin Li (1832905)

A prepubertal CD decreases plasma leptin and cholesterol concentrations in adulthood despite a chronic HFD in Sprague-Dawley male rats. by Ana Aguilar-Lozano (20614619)

nsP4-C483Y or Q192L mutations decrease sensitivity to 4′-FlU. by Peiqi Yin (6533747)

Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

Subjects:

Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

Subjects:

Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

Subjects: